← Back to Search

Behavioral Intervention

Computerized Memory Training for Mild Cognitive Impairment (COMET Trial)

N/A
Recruiting
Led By Alexander C Conley, PhD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

COMET Trial Summary

This trial will use a computerized brain training program to see if it can improve memory in people with Mild Cognitive Impairment.

Who is the study for?
This trial is for adults aged 55-85 with Mild Cognitive Impairment (MCI), who have memory concerns but not severe dementia or Alzheimer's. Participants must be in good health, not pregnant, and fluent in English. They need a study partner available to assist during the study.Check my eligibility
What is being tested?
The trial tests a computer program designed to improve memory by using exercises that stimulate brain plasticity. It aims to see if regular use of this cognitive training can enhance memory function in those with MCI.See study design
What are the potential side effects?
Since the intervention involves cognitive exercises on a computer, side effects are minimal but may include eye strain or headache from screen time, and potential frustration or stress related to the tasks.

COMET Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluate completion rates of nCCR
Evaluate visit duration throughout nCCR treatment
Evaluate visit frequency throughout nCCR treatment

COMET Trial Design

1Treatment groups
Experimental Treatment
Group I: Neuroplasticity-based Computerized Cognitive RemediationExperimental Treatment1 Intervention
Participants will receive a 45-hour of Neuroplasticity-based Computerized Cognitive Remediation
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Neuroplasticity-based Computerized Cognitive Remediation
2020
N/A
~30

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
857 Previous Clinical Trials
672,177 Total Patients Enrolled
Alexander C Conley, PhDPrincipal InvestigatorVanderbilt University Medical Center
1 Previous Clinical Trials
7 Total Patients Enrolled

Media Library

Neuroplasticity-based Computerized Cognitive Remediation (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05332522 — N/A
Mild Cognitive Impairment Research Study Groups: Neuroplasticity-based Computerized Cognitive Remediation
Mild Cognitive Impairment Clinical Trial 2023: Neuroplasticity-based Computerized Cognitive Remediation Highlights & Side Effects. Trial Name: NCT05332522 — N/A
Neuroplasticity-based Computerized Cognitive Remediation (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05332522 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings left in this medical research project?

"Affirmative. According to the clinicaltrials.gov website, this trial is actively recruiting participants with a target enrollment of 20 patients across one location. It was initially posted on August 9th 2022 and last edited on the same day."

Answered by AI

Could I potentially qualify for participation in this experiment?

"This experimental study is enrolling 20 candidates aged between 55 and 85 with evidence of cognitive deterioration. To be eligible, patients must demonstrate a reported memory issue, score 0.5 on the Clinical Dementia Rating 16 Global test, have a Mini-Mental State Exam rating from 22 to 30 (inclusive), show no signs of Alzheimer's disease dementia at screening, record less than or equal to 14 for their Geriatric Depression Scale evaluation, possess a regular companion who visits frequently (10 hours per week minimum), showcase general health without any potential interfering ailments or diseases, not currently pregnant nor lactating if female and two years post-men"

Answered by AI

Does this research opportunity extend to seniors aged 75 or above?

"This clinical trial has a specified age range of 55 to 85 years, and is currently enrolling patients who meet these conditions."

Answered by AI

How many individuals are trialing this medical research?

"Affirmative. As per the clinicaltrials.gov, this research study is now looking for participants to participate in it; the trial was initially publicized on August 9th 2022 and most recently revised on that same day. Approximately 20 individuals have to be enrolled from 1 particular medical site."

Answered by AI
~3 spots leftby Jul 2024